Irradiation of endometrial cancer in patients with medical contraindication to surgery or with unresectable lesions.
In 124 medically inoperable patients with endometrial cancer, the five and ten year actuarial survival rates were 68% and 57%. In 26 patients with technically unresectable endometrial cancer, 26% actuarial survival rates at both five and ten years were seen. Pelvic control at death was 89% in Stage Ia, 78% in Stage Ib, 82% in Stage II, and 62% in Stage III. Sophisticated intracavitary therapy alone or in conjunction with external irradiation appears to give better uterine control rates than does external irradiation alone.
D000328:Adult; D000368:Aged; D003556:Cystitis / Q000209:etiology; D005260:Female; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local; D010386:Pelvic Neoplasms / Q000532:radiotherapy; D011832:Radiation Injuries; D011878:Radiotherapy / Q000379:methods; D011879:Radiotherapy Dosage; D014594:Uterine Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D014599:Uterus; D014621:Vagina / Q000528:radiation effects